BioSpace News Archive

Press Releases

ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally

February 23, 2026
·
19 min read
Press Releases

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

February 23, 2026
·
2 min read
Press Releases

Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

February 23, 2026
·
8 min read
Press Releases

U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status

February 23, 2026
·
3 min read
Press Releases

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

February 23, 2026
·
4 min read
Press Releases

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business Update

February 23, 2026
·
1 min read
Press Releases

BridgeBio to Participate in March 2026 Investor Conferences

February 23, 2026
·
1 min read
Press Releases

Crescent Biopharma to Present at March 2026 Investor Conferences

February 23, 2026
·
1 min read
Press Releases

Subcutaneous RYBREVANT®▼ (amivantamab) approved by European Commission for every-three-week and every-four-week dosing for patients with advanced EGFR-mutated non-small cell lung cancer

February 23, 2026
·
15 min read
Press Releases

This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease

February 23, 2026
·
11 min read